BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3721053)

  • 1. Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease.
    Vercelloni M; Cogo R; Albertini A; Granata M; Rosaschino F
    J Int Med Res; 1986; 14(3):131-6. PubMed ID: 3721053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
    Mayer M; Dúbrava I; Strmen J; Dúbravová H
    Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral sustained-release aminophylline and bronchodilator response to inhaled fenoterol in patients with chronic airflow obstruction.
    Carpentiere G; Marino S; Castello F; Zarcone P; Cipolla G; Baldanza C
    Chest; 1985 Oct; 88(4):576-8. PubMed ID: 4042711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both medicaments.
    Angrisani M; Cazzola M; Loffreda A; Losasso C; Lucarelli C; Rossi F
    Int J Clin Pharmacol Res; 1992; 12(4):165-71. PubMed ID: 1297639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic obstructive pulmonary disease with orally administered aminophylline].
    Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):265-8, 317-8. PubMed ID: 3233685
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral administration of delayed-action aminophylline: analysis of blood levels after multiple doses in aged patients].
    Guggino G; Ricca Rossellini S
    G Clin Med; 1982 May; 63(5):337-45. PubMed ID: 7141176
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
    Clark CJ; Boyd G
    Br J Clin Pharmacol; 1980 Apr; 9(4):359-64. PubMed ID: 7378251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophylline in the outpatient management of decompensated chronic obstructive pulmonary disease.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Chest; 1990 Dec; 98(6):1346-50. PubMed ID: 2123149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined use of intravenous salbutamol and aminophylline on cardiac rhythm in chronic obstructive lung disease.
    Bigi R; Camerone G; Corradetti C; Durante V; Occhi G; Toloni V
    Respiration; 1987; 51(2):119-26. PubMed ID: 3589176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis.
    Reisz G; Pingleton SK; Melethil S; Ryan PB
    Am Rev Respir Dis; 1983 May; 127(5):581-4. PubMed ID: 6846940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
    Cazzola M; Matera MG; Paternò E; Scaglione F; Santangelo G; Rossi F
    J Chemother; 1991 Aug; 3(4):240-4. PubMed ID: 1779258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease.
    Barberá JA; Reyes A; Roca J; Montserrat JM; Wagner PD; Rodríguez-Roisin R
    Am Rev Respir Dis; 1992 Jun; 145(6):1328-33. PubMed ID: 1595998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral aminophylline therapy. Increased dosage requirements in children.
    Zaske DE; Miller KW; Strem EL; Austrian S; Johnson PB
    JAMA; 1977 Apr; 237(14):1453-5. PubMed ID: 576637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of aminophylline on the strength of contraction of the diaphragm in patients with chronic obstructive respiratory insufficiency].
    Murciano D; Aubier M; Curran Y; Pariente R
    Presse Med; 1987 Oct; 16(33):1628-30. PubMed ID: 2959924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 20. Bronchodilator effects on gastric acid secretion.
    Foster LJ; Trudeau WL; Goldman AL
    JAMA; 1979 Jun; 241(24):2613-5. PubMed ID: 439357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.